Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Phase I/II Trial of X-396, a Novel ALK Inhibitor, in Patients With ALK plus NSCLC

Ticiana Leal,Heather Wakelee,Jeffrey Infante,George Blumenschein,Karen Reckamp,Corey Carter,Saiama Waqar,Jon Gockerman,Christine Lovly,Gary Dukart,Kimberly Harrow,Chris Liang,James Gibbons,Leora Horn

JOURNAL OF THORACIC ONCOLOGY（2016）

Cited 0|Views24
No score
Key words
X-396,ALK plus NSCLC
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined